Paraguay Medical Device Registration 2026: Corporate Qualifications, BPAyD Certification and Outsourcing Disclosure

Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

  1. Article 24 addresses companies that manufacture, import, export, distribute, or commercialize devices within Paraguay — holding the qualifying corporate permits is a precondition to filing, not a matter to be settled in parallel with the dossier.
  2. Page 3 of the Instructivo states expressly that a company engaged in storage and distribution must submit the Certificate of Good Storage and Distribution Practices issued by DINAVISA (Certificado de Buenas Prácticas de Almacenamiento y Distribución, BPAyD). The certificate must be current and must cover the activities actually performed by the applicant.
  3. Page 3 of the Instructivo further requires that a domestic manufacturer which outsources part of its production processes or other activities to other companies must declare the outsourced party and the specific processes involved, and submit proof of the contractual relationship with signatures certified by a notary office.
  4. The list of requirements for obtaining device registrations (Lista de Requisitos para la Obtención de Registros D.M.) published on the DINAVISA website additionally lists operating permits, good practice certificates, the single business registration number (RUE), and implant cards, among other items; the official list prevails over any secondary summary.

2. Legal basis

RegulationNumber / referenceDateProvisions
Resolution establishing the requirements for marketing authorization of medical devicesResolución DINAVISA N° 226/20242024-08-27; Article 36 in force as of 2024-09-16Article 24; Article 6 inc. c)
Operational instructions and guide for submitting applicationsInstructivo ITR–DGRS-002, Versión 022024-09-09Page 3 (Depósito y Distribución / outsourcing declaration)
Law instituting health safety procedures and risk prevention mechanismsLey N° 4659/122012Article 9 (authority to inspect premises and operating companies)

Together these three instruments define who may appear before DINAVISA as an applicant: the resolution states the corporate qualification obligation, the Instructivo translates it into the documents actually requested at page level, and Ley N° 4659/12 supplies the inspection powers that make the physical premises part of the compliance picture rather than a paper condition.

The inspection angle deserves separate planning. Because the good practice framework is verifiable on site, the match between the declared activities in the filing and the physical reality of the premises is not only a documentary question. Storage areas, stock records, and traceability documentation may be reviewed in the context of the powers granted under Ley N° 4659/12, and inconsistencies between the BPAyD scope and the declared business category surface quickly. Importers choosing between candidate local partners should therefore include a documentary audit of the permit, the BPAyD, and the RUE registration in partner selection, since deficiencies discovered after signing are far more expensive to correct than a slower partner choice made at the start.

3. Expert insights

Insight one: the sequence of corporate qualification must not be inverted. A common pattern is to assemble the technical dossier first and only then look for a local partner; in Paraguay this order causes rework, because the operating permit is approved by business category (manufacture / import / export / representation / distribution / sale) and by device class separately. If the category or the class of the partner’s permit does not match the target product, the application cannot proceed to acceptance. Corporate qualification should be locked down first, with the permit wording checked against the intended device classification before any dossier work begins.

Insight two: the BPAyD extends compliance requirements into the warehouse. The good storage and distribution practices certificate is issued by DINAVISA and is directed at the actual conditions of the storage and distribution operation — premises, temperature control where relevant, traceability, and handling. For an asset-light trading importer this is a substantive barrier, and it explains why market access in Paraguay depends heavily on local partners that already operate qualified warehousing. The certificate should be verified for scope and validity before contracts are signed, not after.

Insight three: the outsourcing disclosure requirement writes supply chain transparency into the document list. Domestic products require a declaration of the outsourced party and the specific processes plus a notarially certified proof of the contractual relationship; imported products correspond to the outsourcing contract requirement in Article 6 inc. c). The two pathways differ in form but express the same principle: who performed each step must be traceable. A silent subcontractor discovered during assessment damages the credibility of the whole dossier, so every tier of contracted activity should be disclosed in the initial filing.

Insight four: the implant-card and RUE items show that the requirement set reaches beyond the dossier. The requirements list published by DINAVISA brings in the single business registration number (RUE) and, for the products concerned, implant cards, alongside operating permits and good practice certificates. These are institutional identifiers and product-safety accessories, not technical test data, and they belong to the corporate and commercial layer of the applicant. Assembling them is usually faster than the technical work, but leaving them to the end of the project creates avoidable bottlenecks at acceptance, so they should be gathered in the same early phase as the entity qualification documents.

4. Practical recommendations

  1. Make locking down the local entity the first step of the project, and verify that its operating permit category and device class cover the target product.
  2. Verify the validity of the BPAyD certificate before signing the distribution or service contract, and write a continuing maintenance obligation into the agreement.
  3. Where processes are outsourced, prepare the notarially certified proof of the contractual relationship early and disclose the scope of the outsourced processes precisely.
  4. Compare requirements item by item against the Lista de Requisitos para la Obtención de Registros D.M. published on the DINAVISA website; do not rely on second-hand checklists.

5. Verification checklist

  • □ Local entity permit category and device class cover the target product
  • □ BPAyD certificate valid and covering storage and distribution activities
  • □ Outsourcing contract notarially certified for signatures (domestic pathway)
  • □ Outsourced party and specific processes declared
  • □ Requirements compared item by item against the official DINAVISA list

Regulatory information verified as of October 29, 2026.

GRZAN provides medical device registration support in Paraguay for manufacturers, importers, and authorized representatives, covering entity qualification, BPAyD certification, and outsourcing disclosure. Contact info@grzanglobal.com for tailored guidance on this topic.

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail